Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Injection

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44349   clinical trials with a EudraCT protocol, of which   7376   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    16,216 result(s) found for: Injection. Displaying page 462 of 811.
    «« First « Previous 458  459  460  461  462  463  464  465  466  Next» Last»»
    EudraCT Number: 2005-004681-16 Sponsor Protocol Number: NTI-ASP-0502 Start Date*: 2006-04-24
    Sponsor Name:Neurobiological Technologies Inc
    Full Title: ASP I (Ancrod Stroke Program) Study of Acute Viprinex™ for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex™) in Subjects Beginning Treatment within 6 Hour...
    Medical condition: Acute Ischemic Stroke
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Prematurely Ended) GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-004885-18 Sponsor Protocol Number: 1805/2004 Start Date*: 2004-12-30
    Sponsor Name:AZIENDA OSPEDALIERA PISANA
    Full Title: Evaluation of febrile event during emopoietic progenitor cells aferesi post chemotherapy treatment in patients affected by multiple myeloma.
    Medical condition: Multiple myeloma
    Disease: Version SOC Term Classification Code Term Level
    6.1 10028228 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-005110-20 Sponsor Protocol Number: LDCGB/05 Start Date*: 2006-05-04
    Sponsor Name:GEL/TAMO (Grupo Cooperativo Español de Linfoma/Transplante Antólogo de Médula Ósea)
    Full Title: Tratamiento de primera línea del linfoma difuso de célula grande B (LDCGB) con quimioterapia a dosis densas e inmunoterapia (R-CHOP/14) en pacientes mayores de 65 años, y en menores de 65 años de r...
    Medical condition: Linfoma difuso de célula grande B (LDCGB) Diffuse large B-cell lymphoma (DLBCL)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-005453-21 Sponsor Protocol Number: BUPI02/05 Start Date*: 2006-03-01
    Sponsor Name:Laboratorios Inibsa S.A.
    Full Title: Bupivacaína en anestesia odontológica. Estudio comparativo, respecto a la articaína, de su eficacia clínica durante la extracción quirúrgica del tercer molar inferior incluido.
    Medical condition: Dolor en intervención odontológica
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-000504-17 Sponsor Protocol Number: ML 20073 Start Date*: 2006-06-12
    Sponsor Name:Heinrich-Heine-Universität Düsseldorf
    Full Title: Konsekutive Aderlass- und Peginterferon alfa-2a -Ribavirin-Standardtherapie im Vergleich zu einer Peginterferon alfa-2a-Ribavirin-Standardtherapie bei naiven Patienten mit HCV Genotyp 1 und Ferriti...
    Medical condition: Chronische Hepatitis C Infektion
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-002897-23 Sponsor Protocol Number: 107564 Start Date*: 2006-09-05
    Sponsor Name:GlaxoSmithKline Biologicals
    Full Title: An observational study to investigate the incidence of influenza and influenza-related complications, in adults between 50-64 years and elderly adults 65 years and over vaccinated with GSK Biologic...
    Medical condition: Immunization against influenza in male and female subjects aged 50 years and over
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-000935-86 Sponsor Protocol Number: ML19301 Start Date*: 2006-12-27
    Sponsor Name:Roche Pharma AG
    Full Title: Randomized, multicentric, partially double blind placebo-controlled phase II study for examining the influence of Ribavirin on the initial virological response in previous untreated patients with c...
    Medical condition: Chronic Hepatitis C; Genotype 1 Infection
    Disease: Version SOC Term Classification Code Term Level
    8.1 10057212 Hepatitis viral infections HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-003871-11 Sponsor Protocol Number: C87065 Start Date*: 2007-02-06
    Sponsor Name:UCB Pharma S.A.
    Full Title: An open-label, multi-center trial to examine the long term safety, efficacy, and corticosteroid-sparing effect of certolizumab pegol in patients with moderate to severe Crohn's disease who have fai...
    Medical condition: The trial aims to examine the long term safety, efficacy, and corticosteroid-sparing effect of certolizumab pegol in patients with moderate to severe Crohn's disease who have failed tapering of cor...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10011401 Crohn's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-004569-40 Sponsor Protocol Number: ONC-2005-001 Start Date*: 2006-03-23
    Sponsor Name:ISTITUTO CLINICO HUMANITAS
    Full Title: Phase I and II perspective study with Citrate in Liposoma not Pegilate Doxorubicine TLC D-99 in association to Ifosfamide in patients with metastatic soft tissue sarcoma.
    Medical condition: TREATMENT OF PATIENTS AFFECTED WITH SOFT TISSUE SARCOMA IN METASTATIC PHASE
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039491 Sarcoma PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-001016-21 Sponsor Protocol Number: AGMT_ECa Start Date*: 2008-08-28
    Sponsor Name:Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH
    Full Title: Multizentrische Phase II Studie: Induktionschemotherapie und Chemoradiotherapie jeweils in Kombination mit Cetuximab bei Patienten mit nicht-metastasiertem Ösophaguskarzinom
    Medical condition: Unbehandeltes, histologisch gesichertes, nicht-metastasiertes Ösophaguskarzinom (Plattenepithelkarzinom)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10056104 Squamous cell carcinoma of oesophagus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2006-001075-37 Sponsor Protocol Number: TUD-FHCRCD-010 Start Date*: 2007-05-18
    Sponsor Name:University of Technology Dresden
    Full Title: A Multi-center Phase III Study Comparing Myeloablative to Nonmyeloablative Transplantation in Patients with Myelodysplastic Syndrome or Acute Myelogenous Leukemia.
    Medical condition: MDS and AML are predominantly diseases of older patients. For patients with advanced or chemotherapy refractory disease HCT is currently the only strategy that offers curative therapy. Unfortunat...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005007-34 Sponsor Protocol Number: 2006-0101 Start Date*: 2007-04-10
    Sponsor Name:UMCU
    Full Title: Bortezomib re-induction therapy combined with donor lymphocyte infusion in patients with relapsed Multiple Myeloma following allogeneic stem cell transplantation
    Medical condition: multiple myeloma patients with relapse or progression of their disease after receiving an allogeneic stem cell transplantation
    Disease: Version SOC Term Classification Code Term Level
    8.1 10028228 Multiple myeloma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-000115-28 Sponsor Protocol Number: 109817 Start Date*: 2007-07-16
    Sponsor Name:GlaxoSmithKline Biologicals
    Full Title: A phase II, open, non-randomized study designed to evaluate the reactogenicity and immunogenicity of one or two booster administrations of an influenza pandemic candidate vaccine (GSK1562902A) in a...
    Medical condition: Since 1997, avian H5N1 influenza has caused several human infections and high mortality rate in Southeast Asia. Experts warn that the next influenza pandemic is imminent and could be severe. Preven...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2007-004444-71 Sponsor Protocol Number: AMBIDEX Start Date*: 2007-10-22
    Sponsor Name:FOVEA
    Full Title: Traitement préemptif des colonisations multiples à candida chez des patients de réanimation présentant un sepsis
    Medical condition: Colonisation de sites par Candida spp. susceptible de conduire à une candidose systémique chez des patients à risque traités dans un service de réanimation et présentant un état septique
    Disease: Version SOC Term Classification Code Term Level
    9.1 10042939 Systemic candidiasis LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-004255-10 Sponsor Protocol Number: 6078-PG-PSC-164 Start Date*: 2007-11-12
    Sponsor Name:LETI Pharma GmbH
    Full Title: Randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of Depigoid® Grass Mix in patients with al-lergic rhinitis and/or rhinoconjunctivitis with or ...
    Medical condition: Allergic rhinitis and/or rhinoconjunctivitis with or without mild intermitent asthma caused by clinical relevant sensitization against grass pollen.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001723 Allergic rhinitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-002496-14 Sponsor Protocol Number: 2939121 Start Date*: 2007-11-05
    Sponsor Name:Orion Corporation Orion Pharma
    Full Title: Effects of single doses of Stalevo 200 and levodopa/carbidopa 200/50 mg on striatal 11C-raclopride binding potential in Parkinson’s disease patients with wearing-off symptoms. An open, randomised, ...
    Medical condition: Parkinson’s disease
    Disease: Version SOC Term Classification Code Term Level
    9.1 10061536 Parkinson's disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-000440-27 Sponsor Protocol Number: 690701 Start Date*: Information not available in EudraCT
    Sponsor Name:Baxter AG
    Full Title: OPEN-LABEL PHASE IV STUDY TO INVESTIGATE THE SEROPERSISTENCE OF TICK-BORNE ENCEPHALITIS (TBE) VIRUS ANTIBODIES AFTER THE FIRST BOOSTER AND THE RESPONSE TO A SECOND BOOSTER VACCINATION WITH FSME-IMM...
    Medical condition: In this Study the Seropersistence of Tick Borne Encephalitis (TBE) Virus Antibodies after the First Booster and the Response to a Second Booster Vaccination with FSME-IMMUN 0.5ml in Adults will be ...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10043847 Tick-borne viral encephalitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: View results
    EudraCT Number: 2007-001707-38 Sponsor Protocol Number: PN-0709 Start Date*: 2007-07-31
    Sponsor Name:University Hospital
    Full Title: A phase IIIb, open, controlled study to evaluate the immunogenicity, and safety of 7PCV Prevenar vaccine in pre-term infants
    Medical condition: Premature children suffer from large variety of different accompanying diseases. Pneumoccocal diseases creates substantial proportion especially in children with undergoing diseases of respiratory ...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10054047 Pneumococcal sepsis LLT
    9.1 10027253 Meningitis pneumococcal LLT
    Population Age: Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-004320-36 Sponsor Protocol Number: DMS/AVASTIN 2006 Start Date*: 2006-07-25
    Sponsor Name:AZIENDA OSPEDALIERA SENESE
    Full Title: Intravitreal Bevacizumab (Avastin) for neovascular age-related macular degeneration
    Medical condition: Viasual acuity loss
    Disease: Version SOC Term Classification Code Term Level
    9.1 10015919 Eye disorders SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-003417-14 Sponsor Protocol Number: GEICAM 2006-10 Start Date*: 2007-09-14
    Sponsor Name:Grupo Español de Investigación en Cáncer de Mama (GEICAM)
    Full Title: Ensayo fase III aleatorizado, multicéntrico, abierto, de grupos paralelos para comparar la eficacia y tolerabilidad de Fulvestrant (Faslodex®) durante tres años en combinación con Anastrozol (Arimi...
    Medical condition: Postmenopausal women with operable breast cancer and positive hormonal receptors who are eligible to be treated with adjuvant hormonotherapy.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10006187 Breast cancer LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 458  459  460  461  462  463  464  465  466  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Jul 17 09:29:37 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA